Medpace Holdings, Inc.
Medpace Holdings, Inc., a leading global clinical research organisation, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1992, Medpace has established itself as a trusted partner in the pharmaceutical and biotechnology industries, specialising in full-service clinical development and regulatory consulting. The company offers a comprehensive range of services, including clinical trial management, data management, and biostatistics, which are tailored to meet the unique needs of its clients. Medpace's commitment to quality and efficiency has positioned it as a preferred choice for sponsors seeking to navigate the complexities of clinical trials. With a strong track record of successful project delivery and a focus on therapeutic expertise, Medpace Holdings, Inc. continues to achieve significant milestones, solidifying its reputation as a key player in the clinical research landscape.
DitchCarbon Score
How does Medpace Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medpace Holdings, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medpace Holdings, Inc.'s reported carbon emissions
Medpace Holdings, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. As a result, there are no reported figures for their Scope 1, 2, or 3 emissions. The absence of emissions data suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate their environmental impact. Medpace's future climate commitments may align with these trends, focusing on reducing carbon footprints and enhancing sustainability practices. However, without specific data or targets, it is challenging to assess their current position in relation to climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medpace Holdings, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
